Please try another search
Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company’s platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.
Name | Age | Since | Title |
---|---|---|---|
Bruna Marini | 37 | - | Co-founder, COO & Executive Director |
Ignazio Pellecchia | 54 | - | Standing Auditor |
Lawrence Banks | - | - | Member of Scientific Board |
Joseph R. Kates | - | - | Chairman of Scientific Board |
Gordon Whiteley | - | - | Member of Scientific Board |
Robert C. Gallo | 85 | - | Member of Scientific Board |
Davide Zella | - | - | Member of Scientific Board |
Alberto Maria Camilotti | 48 | - | Chairman of the Board of Statutory Auditors |
Stefano Lo Priore | 56 | 2023 | Non-Executive Chairman |
Massimo Fulvio Campanelli | 49 | 2024 | Standing Auditor |
Carlo Montenovesi | 71 | 2024 | Executive Director |
Cristina Sbaizero | 52 | 2024 | Independent Director |
Nicola Basile | 45 | 2024 | CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review